Nalaganje...
Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
An available supply of intravenous immunoglobulin (IVIG) is essential for individuals with primary humoral immunodeficiency. A shortage in 1997 prompted the Food and Drug Administration (FDA) to revise guidelines for the licensure, production, and distribution of new IVIG products, including the sta...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer-Verlag
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501191/ https://ncbi.nlm.nih.gov/pubmed/22968971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s15010-012-0323-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|